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Transmembrane helixE1 and E2 are two hepatitis C viral envelope glycoproteins that assemble into a heterodimer that is essential for
membrane fusion and penetration into the target cell. Both extracellular and transmembrane (TM) glycoprotein
domains contribute to this interaction, but study of TM–TM interactions has been limited because synthesis and
structural characterization of these highly hydrophobic segments present signiﬁcant challenges. In this NMR
study, by successful expression and puriﬁcation of the E2 transmembrane domain as a fusion construct we
have determined the global fold and characterized backbone motions for this peptide incorporated in phospho-
lipid micelles. Backbone resonance frequencies, relaxation rates and solvent exposure measurements concur in
showing this domain to adopt a helical conformation, with two helical segments spanning residues 717–726
and 732–746 connected by an unstructured linker containing the charged residues D728 and R730 involved in
E1 binding. Although this linker exhibits increased local motions on the ps timescale, the dominating contribu-
tion to its relaxation is the global tumbling motion with an estimated correlation time of 12.3 ns. The positioning
of the helix–linker–helix architecture within themixedmicelle was established by paramagnetic NMR spectros-
copy and phospholipid-peptide cross relaxationmeasurements. These indicate thatwhile the helices traverse the
hydrophobic interior of the micelle, the linker lies closer to the micelle perimeter to accommodate its charged
residues. These results lay the groundwork for structure determination of the E1/E2 complex and a molecular
understanding of glycoprotein heterodimerization.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C is the second most common chronic viral disease world-
wide, with an estimated 180 million people afﬂicted by the disease
or identiﬁed as carriers. It is caused by the hepatitis C virus (HCV)
of the ﬂaviviridiae family, and symptoms include chronic hepatitis,
cirrhosis, hepatic carcinomas and extra-hepatic diseases [1,2]. It presents
a major concern in healthcare systems as it can be transmitted via blood
transfusion, organ transplantation and improperly sterilized surgical
equipment. Understanding of HCV biology is surprisingly limited when
considering its prevalence and signiﬁcance in human health. As a result,
existing therapeutic measures are often less than satisfactory, character-
ized by mediocre response levels and undesirable side-effects [3–5],eridine 1-oxyl benzoate; CPMG
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,although novel promising therapeutic strategies have been introduced
lately [6–8]. The HCV genome encodes a polypeptide precursor which
is ~3000 amino acids long and undergoes post-translational modiﬁca-
tion and cleavage into over 10 mature proteins [3,9,10]. Of these, the
structured proteins, the core protein and envelope glycoproteins E1
and E2, form the viral particle, while the non-structured proteins are
involved in the replication cycle and its regulation through protease,
helicase and polymerase activities [11].
The envelope glycoproteins E1 and E2 are type I membrane-
embedded proteins (MPs), each comprised of a large N-terminal
ectodomain, a single membrane spanning domain and a short
C-terminal cytoplasmic tail. They assemble into a heterodimer which
allows the virus to fuse to the host membrane and thus is a critical
contributor to its ability to insert its genetic material [12]. The structure
of an E2-core/antibody complex was recently determined, showing the
E2 ectodomain to form an immunoglobulin-fold β-sandwich ﬂanked
by additional protein layers [13]. Well established is the interaction
between the two ectodomains and cell-surface receptors, accounting
for their contribution to the fusion process [14–17]. In particular, the
E2 ectodomain recognizes the host tetraspannin CD81 receptor, leading
to membrane fusion and viral entry [15,18,19]. In addition, current
studies have focused on anti-E2 antibodies [20] or E2-derived peptides
[21] as potential HCV therapies. The importance of the stem region,
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similarly demonstrated [22–24]. In contrast, the contributions of the
glycoprotein transmembrane (TM) domains are poorly understood
due to the challenging nature of structural studies in MPs. Besides
directing and anchoring E1 and E2 to the endoplasmic reticulum and
acting as signal sequences, the E1 and E2 TM domains contribute to
the afﬁnity of the glycoprotein heterodimer. Mostly hydrophobic in
nature, the TM domains do uncharacteristically contain charged
residues as well, K370 on E1 and both D728 and R730 on E2 [25–27].
Notably, mutations at these positions and at the G354VLAG358 element
of E1 result in a 3- to 4-fold reduction in heterodimer formation and cel-
lular fusion assays [26,27] (Fig. 1A). While the TM-domains are
predicted to be α-helical, structural information in a biological
environment is currently unavailable.
The heterodimer of E1 and E2 TM domains forms a bitopic system,
an assembly common to over half of membrane-associated proteins
(MPs) in analyzed genomes [28]. Pathology-causing mutations have
been found in several bitopic systems, highlighting the role played by
these domains in both health and disease [29,30]. In bitopic systems
two single-TM helical MPs assume a parallel orientation and associate
within the membrane via non-covalent interactions. The reversible
association between two membrane-spanning domains is a well-
known paradigm for cellular signaling [31], and has attracted signiﬁcant
attention in recent studies [32]. Structural studies of MPs are hampered
by the need for solubilizing the protein in a membrane-mimicking
environment, making it harder to obtain homogeneous samples and
increasing the effective size of the structural target. For purposes of
study by high-resolution NMR MPs are typically stabilized in micelles
or disk-like bicelles formed by detergents or phospholipids [33–36] or
assembled nano-discs [37,38], while solid-state NMR studies utilize
phospholipid bicelles, vesicles or oriented bilayers for stabilization of
membrane peptides [39–42]. Generally, NMR offers the dual advantage
of structural investigation under close-to-native conditions, and sensi-
tivity to dynamic processes on a wide range of timescales unobservable
using other methods [43–45]. In addition, several NMR-based methods
are available for studying protein-protein interactions even with low
afﬁnities [45–48]. The latest achievements of NMR in addressing MPs
and speciﬁcally bitopic systems have been presented in excellent recent
reviews [32,49].
In light of the importance of a structural understanding of E1/E2
heterodimerization, and pursuant to our previous investigation of
the E1 membrane-spanning domain [50], we have applied solution
NMR to characterize the TM domain of E2 (E2-TM) from the HCV
envelope glycoprotein. We have successfully produced and puriﬁed a
double Cys-to-Ser mutant version of this peptide as a maltose-binding
protein (MBP) fusion polypeptide, and characterized its behavior in
1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) (LPPG)Fig. 1. The E1/E2 glycoprotein heterodimeric system inHCV. Left, schematic representation of the
in the viral membrane. Right, membrane-spanning sequences of E1 and E2 with residues knowmicelles. The micelle-spanning region was deﬁned as residues 717–746,
and was shown to contain two helical regions connected by a non-
helical hinge linker that coincides with charged residues D728 and
R730. Analysis of relaxation rates indicates increased ﬂexibility in the
linker region, although the dominating motion remains the global
tumbling of the mixed micelle, with an estimated correlation time of
12.3 ns. Paramagnetic spectroscopy and cross-relaxation measure-
ments suggest that the helical segments span the hydrophobic micelle
interior, while the linker is located closer to the micelle perimeter,
thereby accommodating the unpaired charged residues in E2-TM.
Thus, binding of E1-TM to E2-TM may signiﬁcantly affect its structure
and orientation within the biological membrane.
2. Experimental
2.1. Media and solvents
DNA primers, the Isogro-DCN supplement for triply labeled media
and 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl benzoate (4-HTB)
were obtained from Sigma-Aldrich (St. Louis, MO, USA). Isotopically
labeled chemicals for constructing labeling media, including 2H2O,
13C-labeled glucose and 15NH4Cl, were purchased from Cambridge
Isotope Laboratories (Andover, MA, USA). LPPG was purchased from
Avanti Polar Lipids, Inc. (Alabaster, AL, USA). M9 minimal media
was made as previously described [51], with substitution of 15NH4Cl,
13C6-glucose and 2H2O for producing triply-labeled E2-TM. HPLC
grade solvents HCOOH and isopropanol were purchased from Biolabs
(Jerusalem, Israel).
2.2. Cloning of the E2-TM sequence
Cloning of the double mutant construct MBP-(His)6-TEV-E2-Arg6
C732S/C734S was performed in three steps. First the coding sequence
of E2-TM (purchased from GeneArt, Germany) was inserted into a
pETMBPH vector, a modiﬁed pET28a(+) construct containing the
maltose binding protein (MBP) coding sequence [52], using a restriction
site-free cloning method between the KpnI restriction site and stop
codon [53]. Next, the Arg6 segment was inserted following E2-TM
sequence (vide infra) to increase solubility. Each of the primers
((phos)-Arg6-5′ and Arg6-3′) was designed with an additional coding
sequence for three arginine residues, and PCR reaction followed by
ligation yielded the desired vector (also conﬁrmed by DNA sequencing).
In the last PCR reaction site directedmutagenesis using primers (phos)-
CysToSer-5′ and CysToSer-3′ followed by ligation provided the ﬁnal
MBP-His-Tev-E2-Arg6 C732S/C734S construct. The ﬁnal plasmid was
ampliﬁed in Escherichia coli DH5α cells and its sequence conﬁrmed,
and it was used to transform an E. coli BL21(DE3) expression system.HCVE1 (light gray) andE2 (dark gray) glycoproteins, emphasizing the segments embedded
n to be involved in heterodimerization underlined. Below, the E2-TM construct in detail.
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E2-TM expression was performed in M9minimal medium [51], and
15N- and 13C-isotope labeling were achieved using 1 g/L 99% 15NH4Cl
and 2.5 g/L 99% 13C6-glucose, respectively. The expression protocol
closely followed the procedure used to express a similar membrane-
spanning peptide in an earlier study [50]. Brieﬂy, IPTG-induced cultures
were grown overnight at 27 °C and harvested by centrifugation.
For puriﬁcation of E2-TM cells were lysed by homogenization
(C5 homogenizer, Avestin) and the MBP-tethered E2-TMwas captured
by Ni2+-afﬁnity chromatography. This fraction was collected, dialyzed
overnight and incubated with TEV protease (1:10 wt\wt) for 3–5 h at
30 °C, resulting in quantitative cleavage (N95%) of the E2-TM peptide
from its MBP carrier. The peptide was then separated from MBP
by preparative reverse-phase HPLC on a C4 column (Phenomenex,
Torrance, CA, USA) using a H2O/isopropanol linear gradient (30:70
to 50:50) containing 10% (vol/vol) formic acid at 60 °C (Supporting
Information, Figure S1). E2-TM-containing fractions were pooled and
lyophilized in preparation for solubilization in phospholipid for NMR
experiments. Protein concentration was determined by measuring the
absorbance at 280 nm, based on a speciﬁc absorbance of 2.3 OD280
for a 1 mg/ml solution.
2.4. Circular dichroism measurements
CD experiments were acquired on a Chirascan polarimeter (Applied
Photophysics) for a 15 μM sample of LPPG-solubilized E2-TM in 20 mM
NaPi buffer, pH 6.5, placed in a temperature-controlled cuvette with a
0.1 cm pathlength. The experiment was repeated three times and
subtracted from a measurement of an identical buffer sample. Results
were analyzed using the MP180 module of the DichroWeb platform
for the 190–240 nm range [54].
2.5. NMR spectroscopy
All 2D- and 3D-NMR measurements were conducted on a DRX700
Bruker spectrometer using a cryogenic triple-resonance TCI probehead
equipped with z-axis pulsed ﬁeld gradients. Sample conditions for all
E2-TM preparations were 0.2–0.5 mM peptide in buffer containing
20 mM phosphate buffer, with pH values of 6.0–6.5, 20 mM NaCl, 7%
2H2O, and 40 mM of the phospholipid LPPG. Samples were placed in
Shigemi (Shigemi, Allison, PA, USA) or Wilmad (Wilmad Labglass,
Vineland, NJ, USA) NMR tubes. Measurements were conducted (unless
stated otherwise) at 318 K. TROSY- (tr-) and non-TROSY versions of
the 1H,15N-HSQC for screening of measurement conditions were
acquired using a standard sequence run for 30–60 minutes. For back-
bone assignment, TROSY-based triple resonance HNCO, HNCA,
HN(CO)CACB, and HNCACB experiments using sensitivity-enhanced
echo-antiecho detection [55] were acquired for triply labeled
2H,13C,15N-E2-TM. Triple-resonance experiments were typically
acquired with 512 complex points and an acquisition time of 52.2 ms
in the observed dimension and 32–36 complex points and an acquisi-
tion time of 20.2–22.8 ms in the 15N dimension. In the 13C dimension,
experiments with 13CO (13Cα) evolution were acquired with 32–40
complex points and 21.2–26.5 (7–7.5) ms acquisition time, and experi-
ments with 13Cα/β evolution were acquired with 56–64 complex points
and 5.3–6.1 ms acquisition time. All spectra were processed using the
TopSpin 2.1 package (Bruker BioSpin, Karlsruhe, Germany). Chemical
shifts were referenced indirectly against 4,4-dimethyl-4-silapentane-
1-sulfonic acid (DSS).
Relaxation measurements were conducted in scan-by-scan inter-
leaved fashion with a tr-HSQC spectrum for readout at static magnetic
ﬁeld of 16.4 T and 318 K. Longitudinal relaxation rates (R1) were
estimated from a series of decay spectra with delays of 2 (reference
spectrum), 252, 502, 752, 1002, and 1252 ms. Similarly, transverse
relaxation rates (R2) were estimated from a series of decay spectraacquired in CPMG-form with relaxation times of 16.96 (reference
spectrum), 33.92, 50.88, 67.84, 84.80, and 101.76ms. The heteronuclear
15N-{1H}-NOEs (hetNOEs) were determined by recording pairs of inter-
leaved spectra with and without proton saturation during the recycle
delay, with similar acquisition times in both dimensions. In each
measurement a total of 32–40 transients were collected per t1 experi-
ment and delays between scans were 3.0 s; in the hetNOE experiment
this delay was set to 5.9 s. Total experiment time for each relaxation
measurementwas 60–72 h. For extraction of R1 and R2 relaxation inten-
sities were ﬁt to an exponential decay function using the Bruker
TopSpin 2.1 Dynamics suite, and hetNOEs were derived from the inten-
sity ratio in reference and attenuated spectra. Analysis of relaxation
rates using the model-free approach was performed using the Matlab-
based DYNAMICS program [56,57].
The rate of exchange of amide protons with bulk 2H2O-based
solution was estimated by comparing two tr-HSQC spectra, one
acquired for a 0.2 mM sample of 2H,13C,15N-labeled E2-TM, and the
other after 7-fold dilutionwith 2H2O-based buffer of otherwise identical
composition. In spin-label- (SL)-mediated relaxationmeasurements the
intensity ratio of tr-HSQC cross-peaks before and after addition of the
stable nitroxide radical 4-hydroxy-2,2,6,6-tetramethylpiperidine
1-oxyl benzoate (4-HTB) (ﬁnal concentration 0.2 mg/ml) was used as
a measure of the proximity of each amide proton to the unpaired
electron. For cross-relaxation effects between micelle protons and the
E2-TM amide protons a tr-HSQC experiment was preceded by a l.2 s
irradiation period followed by a 0.6 s recovery delay. Irradiation was
centered at 2.8 kHz upﬁeld of the LPPG 1H signals as a control and in
turn upon the LPPG methyl group, overlapping methylene groups
(H4–15) and the penultimate methylene (H3), all in interleaved fashion.
Selective irradiation (as veriﬁed by observing its effects on the LPPG
1H-NMR spectrum) was achieved using repeated REBURP inversion
pulses with a maximum γB1 of 208.8 Hz.
3. Results
3.1. Biosynthesis of E2-TM and sample preparation
Due to their hydrophobicity, TM domains are notoriously difﬁcult to
prepare using solid-phase synthesis methods, since they exhibit a
strong aggregation tendency that limits the efﬁciency of amino acid
coupling. We therefore employed recombinant techniques to express
the E2 transmembrane domain peptide fused to a carrier protein
designed to enhance expression levels and solubility following a strate-
gy that proved successful in a previous study of the E1 membrane
spanning domain. This avoided aggregation of the hydrophobic E2
membrane-spanning peptide during expression and puriﬁcation, and
still allowed later separation between carrier protein and peptide after
cleavage using reverse-phase HPLC methods [50]. The E2 peptide
was chosen from a consensus sequence of viral strains and based on a
previous prediction of the membrane spanning region as including
residues 714–746 [58,59]. In the course of optimizing expression and
puriﬁcation protocols we established two additional factors inﬂuencing
the ﬁnal yield of the puriﬁed E2-derived peptide, (i) addition of charged
residues to the hydrophobic peptide to increase its solubility once the
carrier protein is removed, and (ii) mutation of two cysteine residues
in the E2 sequence to avoid intermolecular disulﬁde bridging and conse-
quent oligomerization. Previous studies had not established an involve-
ment in binding for these cysteine residues [26,27]. Accordingly, the
ﬁnal construct fashioned, affording peptide yields sufﬁcient for the
NMRstudy, includedmaltose bindingprotein (MBP) linkedby a tobacco
etch virus (TEV) protease cleavage site to the double Cys-to-Ser mutant
E2 peptide followed by a hexa-arginine tail. An additional ﬁve residues
preceded this sequence due to cloning considerations. Overall, the ﬁnal
44-mer double-mutant peptide used in this study was (GTDPK)
I714KWEYVLLLFLLLADARVSASLWMMLLIAQAEA746(RRRRRR), referred
to as E2-TM (Fig. 1B). Expression and puriﬁcation of this construct
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lized E2-TM peptide which could be solubilized in a detergent of choice
in preparation for NMR and CD experiments.
3.2. Structural characterization of E2-TM in LPPG micelles
Previous studies have established that the choice of detergent for
solubilization of membrane peptides is a critical factor in obtaining
NMR-amenable samples with biological relevance [33–36]. We used 1-
palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) (LPPG), a
phospholipid known to be generally suitable for NMR studies of mem-
brane proteins [33] to solubilize lyophilized E2-TM. Circular dichroism
(CD) characterization of E2-TM in LPPG micelles produced a curve with
characteristic minima at 208 and 222 nm, indicating the prevalence of
α-helical secondary structure (Fig. 2A). Using the DichroWeb MP180
module for analyzing CD results of membrane-embedded peptides [54]
we determined the proportion of helical character in E2-TM to be 40%.
This value is consistent with our expectation that E2-TM adopts a he-
lical conformation in the membrane-mimicking environment.
A comparison between the relaxation-optimized (TROSY) and
regular versions of the 1H,15N-HSQC indicated that the former afforded
better signal-to-noise for E2-TM (Supporting Information, Figure S2)
and was subsequently utilized for evaluating the quality of NMR
samples. The TROSY-HSQC (tr-HSQC) NMR spectrum of this sample
provided further evidence that E2-TM was stabilized in native confor-
mation by LPPG micelles. A 0.25 mM E2-TM sample at a temperature
of 318 K and a static magnetic ﬁeld of 16.4 T afforded a well-resolved
spectrum within 20-30 minutes of measurement time. Although some
overlap between cross-peakswas observed, as is characteristic of helical
proteins, 33 resolved backbone 1H–15N moieties (of the expected 36)
could be detected in the spectrum. Two indole 1H–15N groups, ema-
nating from residuesW716 andW736, were clearly seen, and the 15NFig. 2. Characterization of E2-TM solubilized in LPPGmicelles. (A) CD curve for E2-TM in 20mM
with annotation of amide peaks. The inset shows the indole ring cross-peaks ofW716 andW73
from the tr-HN(CO)CACB (left in every pair) and tr-HNCACB(right in every pair) spectra of E2-TM
assignment of resonances. Here this is shown for residues V731SASLW736, with 13Cα (13Cβ) resupﬁeld region of the spectrum was devoid of peaks, as expected for
E2-TM which lacks glycine residues (Fig. 2B). Membrane peptides
poorly stabilized and suffering from hydrophobic mismatch or ag-
gregation typically exhibit a weak tr-HSQC spectrum due to hetero-
geneous dispersion in the membrane-mimicking environment or
exchange-mediated spectral broadening [33,34,36,60]. Therefore,
experimental evidence is consistent with a well-behaved sample of
sufﬁciently pure E2-TM amenable to further study by NMR.
A 2H, 13C, 15N-triply labeled E2-TM peptide was used to acquire
TROSY versions of the HNCO, HNCA, HN(CO)CACB, and HNCACB
experiments [55] at 318 K. The HNCO experiment correlated each
1H,15N-pair with the 13C′ nucleus of the preceding residue, alleviating
any overlap between HSQC peaks and affording chemical shifts of
carbonyl nuclei. The other three experiments similarly correlated
each 1H,15N-pair with the two adjacent 13Cα nuclei (in the case of
the HNCA), the 13Cα/13Cβ of the preceding residue (in the case of the
HN(CO)CACB) and the two adjacent 13Cα/13Cβ pairs (in the case of
the HNCACB). The combination of these spectra was sufﬁcient to assign
peptide backbone and 13Cβ chemical shifts utilizing well known
methodologies [61]. Fig. 2C shows typical strip-plots demonstrating
the ‘backbone-walk’ based on these connectivities and the resulting
assignment of the ﬁngerprint tr-HSQC spectrum (Fig. 2B). The
resonance assignment of E2-TM solubilized in LPPG micelles has been
deposited in the Biological Magnetic Resonance Data Bank (BMRB),
under accession code 19636.
3.3. Secondary structure in LPPG-solubilized E2-TM
Secondary chemical shifts are an excellent indicator of secondary
structure in proteins [62–65]. Analysis of 13C′, 13Cα, and 13Cβ secondary
chemical shifts for LPPG-solubilized E2-TMshows thepeptide to adopt a
helical conformation. Secondary chemical shifts exhibited typical valuesNaPi pH 6.8, 10 mM NaCl, 40 mM LPPG at 318 K. (B) tr-1H,15N-HSQC spectrum of E2-TM
6. Asterisks denote cross-peaks from sidechain or non-E2 residues 1H-15N pairs. (C) Strips
in LPPGmicelles, demonstrating the ‘backbonewalk’ between adjacent residues allowing
onances connected in solid (dashed) lines.
Fig. 4. Amide proton exchange rates of the E2-TM peptide in LPPGmicelles. Bars show the
ratio between tr-HSQC peaks acquired for a 0.4 mM sample of E2-TM in LPPG micelles in
7% 2H2O (80 min) and the same sample immediately after 7:1 dilution into 2H2O-based
buffer (12 h). Fast amide proton exchange and relaxation dictate a ~0.35 ratio for fully ex-
changeable protons. Residues with a 3-fold higher ratio or more are denoted with ﬁlled
circles.
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to −2 for 13Cβ nuclei in two segments spanning residues 717–726
(α1) and 732–746 (α2). For residues 714–715 and 727–730 and the
non-native E2-TM residues secondary chemical shifts were far less
signiﬁcant, indicating the boundaries of the E2-TM helical regions
(Fig. 3). In particular, residues connecting the two helices appear to
be an unstructured linker that coincides with the location of charged
residues D728 and R730. Analysis of secondary chemical shift data
using the TALOS platform [66] exhibited an average helical population
of 80% for α1 residues and 90% for α2 residues, as opposed to 40% for
the linker residues 727–730, whose random coil population exceeded
50% (Fig. 3, bottom panel).
Conﬁrmation of these ﬁndings was obtained from ameasurement of
amide proton exchange rates upon exposure to 2H2O. Typically these
rates are estimated by following signal loss upon transfer of the sample
to 2H2O.However, solubilization of lyophilized E2-TM in the presence of
phospholipid is relatively time-consuming, dictating a more qualitative
and useful measure of exchange rates. A 2H,13C,15N-labeled E2-TM
sample was diluted 7-fold into an identical 2H2O-based buffer, and
tr-HSQC spectra before and after dilution were compared, with the
length of the second experiment adjusted to match the signal-to-noise
level of the initial one. Since both exchange and relaxation rates contrib-
ute to the results, a quantitative interpretation of the intensity ratio
between the two experiments is not straightforward. However, on the
qualitative level exchangeable amide protons quickly reﬂect the new
H2O:2H2O ratio, whereas protected sites show an excess of protonated
amides. E2-TM amide protons exhibiting relative protection from
solvent exchange included residues 720–726 and 738–743. Both
segments are found within the two known helices, including central
helix residues but not those in the ﬁrst 1–2 helical turns (Fig. 4). The
main contribution to protection from exchange is provided by a combi-
nation of hydrogen-bonding accompanying secondary structure and
accessibility to bulk solvent, closely correlated to the radial positioning
within the micelle. Overall, results of both chemical shift and solvent
exposure experiments conﬁrm the location of the two helices in
E2-TM and are consistent with a helix–linker–helix arrangement.Fig. 3. Secondary chemical shifts of E2-TM deﬁne its helical nature. Secondary chemical
shifts measured along the E2-TM backbone. Shown are values for (A) 13C′, (B) 13Cα,
(C) 13Cβ nuclei in LPPG micelles. (D) TALOS [66] predicted populations in helical (solid
black line) and random coil (gray line) conformations.3.4. Order and ﬂexibility on the ps–ns timescale along the E2-TM sequence
15N relaxation rates are a well-accepted reporter on global and
local motions on the ps–ns timescale in the peptidic backbone [43,44].
R1 and R2 rates and hetNOEs were measured for LPPG-solubilized
E2-TM at 318 K and 16.4 T. Two E2-TM segments, spanning residues
717–726 and 732–746, exhibited relaxation parameters consistent
with rigid domains, in close agreement with the α1 and α2 helical
regions identiﬁed earlier. Typical relaxation rates observed for the α1
(α2) segment (ranges are ±1 SD in all cases) were R1 values of
0.88–0.94 (0.80–0.88) s−1, R2 values of 16.7–19.3 (16.0–20.0) s−1 and
hetNOE values of 0.70–0.80 (0.76–0.84) (Fig. 5A). R1 and R2 rates of
residue W716 (adjacent to α1), residues A727, D728, R730 and V731
in the linker region connecting the two helices (residue A729 afforded
a cross-peak that was too weak for this analysis), and the two arginine
residues adjacent to theα2 segment were similar to those of the helical
region, although their hetNOE was lower. In contrast, residues preced-
ing α1 and the last four arginine residues exhibited elevated R1 values
(1.14–1.28 s−1) and reduced R2 and hetNOE values (5–10 s−1 and
0.27–0.53, respectively) suggesting increased motions on the ps–ns
timescale and ﬂexibility in these regions (Fig. 5A). Together these
results deﬁne the micelle-spanning region (residues 717–746) of the
peptide, with residue W716 and the ﬁrst two arginines representing
transitional regions, most likely located at the phospholipid-water
interface.
A more quantitative view of order and ﬂexibility of all E2-TM
residues (inside and outside the LPPGmicelle) was afforded by reduced
spectral density [67–69] and model-free [70,71] analyses of relaxation
rates. The former determines the relative contributions of motions on
different timescales to the overall relaxational behavior, and the latter
differentiates speciﬁcally between contributions of local motions on
the backdrop of a global molecular tumbling. The membrane spanning
region is clearly identiﬁed by typical J0 values of ~5 ns and negligible
contributions of JN and J0.87H values, and high generalized square order
parameters (0.85 b S2 b 0.95) with limited local motions. Local motions
are more prevalent in α1 compared to α2, indicating the latter is more
rigid. A sharp decrease in J0 and S2, and an increase in J0.87H and in local
motions for the E2-TM termini indicates that these residues are located
outside the micelle. The linker connecting α1 and α2 exhibited a small
yet signiﬁcant increase in fastermotions (JN and J0.87H), while maintain-
ing S2 values indicative of rigidity. This suggests that despite the
increased backbone motions, consistent with the lack of secondary
structure in this segment, the helix–linker–helix architecture remains
relatively well-ordered. Model-free analysis indicated a global tumbling
time of 12.3 ± 0.3 ns for the E2-TM-containing micelle at 318 K. Based
on the Stokes–Einstein equation for rotational diffusion of a spherical
body, and assuming a viscosity of 0.59 cp for an aqueous sample at
318 K, this corresponds to a hydrodynamic radius of ca. 28 Å for the
mixed LPPG micelle, in agreement with results of a previous study [72].
Fig. 5.Relaxationmeasurements report onps–nsdynamics of the E2-TM-LPPG assembly. Backbone 15N relaxation ratesmeasured for 2H,13C,15N-labeled E2-TMat a staticﬁeld of 16.4 T and
318 K. (A) Shown are longitudinal relaxation R1 (top), transverse relaxation R2 (middle) and the heteronuclear 15N-{1H}-NOE (bottom). Typical errors in relaxation rate measurements
were 4-6%. (B) Analysis of relaxation rates using reduced spectral density mapping [67–69] (panels 1–3) and the model-free approach [70,71] (panels 4–5). Shown are the J(0), J(ωN)
and J(0.87ωH) contributions to relaxation at 16.4 T (panels 1–3). Also shown are the generalized squared order parameter (panel 4) and local backbone motions (panel 5) along the
E2-TM sequence. In panel 4 dark bars designate residues forwhich the transverse relaxation rate suggested an exchange contribution. In panel 5ﬁlled and empty circles representmotions
on the ps (right axis) and the ns (left axis) timescales, respectively. In both ﬁgures, DPK and RRRRRR designate E2-TM residues which are not native to E2.
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Our earlier ﬁndings established a helix–linker–helix architecture
for E2-TM, and determined that the linker segment lacks secondary
structure and exhibits marginal ﬂexibility. To further characterize
our system by determining the relative positioning of the peptide
within the micelle, we added to the mixed micelle 0.2 mg/ml of
4-hydroxy-TEMPO benzoate (4-HTB), a water-insoluble nitroxide
radical, and, after sonication to ensure its incorporation into themicelle,
followed its paramagnetic effect upon the E2-TM peak intensities.
Under these conditions a decrease in peak intensity should reﬂect a
relaxation-enhancement effect due to the proximity of the unpaired
electron to a given amide proton. Comparison of tr-HSQC spectra before
and after addition of 4-HTB revealed a strong effect (decrease of
40%–50%) for residues 728-732, and a smaller yet still signiﬁcant effect
(20%–25%) for adjacent residues 733–735. In addition, the signals of
several residues at the E2-TM termini were weakened in the presenceFig. 6. Effect of paramagnetic spin-labels on E2-TM amide protons. Top, ratio of tr-HSQC
peak after (ISL) and before (I0) the addition of 0.1 mg/ml 4-HTB to 0.2 mM E2-TM in
40 mM LPPG, 20 mM KPi buffer pH 6.7, 20 mM NaCl, and 0.01% NaN3. Bottom, change in
position of tr-HSQC peaks, deﬁned as ΔHN = (ΔH2 + (ΔN/5)2)½, where ΔH and ΔN are the
individual change in 1H and 15N shifts, respectively, upon titration to ﬁnal concentrations
of 0–8 mMMn2+. Values shown are the change in ΔHN in ppb per mM of titrated Mn2+.
DPK and RRRRRR designate E2-TM residues which are not native to E2.of 4-HTB, in some cases (K715, K(−1) preceding the E2 residues,
and R3,4,5 of the hexa-arginine tail) beyond detection (Fig. 6, top).
Since the latter residues were previously located outside the micelle,
this result is consistentwith the linker being positioned near themicelle
headgroups. It also predicates a more diffuse distribution of 4-HTB than
anticipated.
With the aimof further conﬁrming these resultswe followed changes
in the E2-TM ﬁngerprint spectrum during the course of aMn2+ titration.
The Mn2+ ion, unable to penetrate into the micelle, has an isotropic
g-tensor, and is therefore expected to selectively enhance the relaxation
of amide groups in its vicinity. Surprisingly, the E2-TM spectrum exhib-
itedMn2+-induced chemical shift changes, indicating that the paramag-
netic center had lost its symmetry. We attributed this to a binding of the
ion to the mixed micelle, most likely to the phospholipid headgroup,
largely in excess over other potential ligands such as negatively charged
peptide residues. Fig. 6 (bottom) demonstrates the magnitude of this
pseudocontact shift effect along the E2-TM backbone.While local effects
may contribute to these effects, as reﬂected in the relatively large change
in E717 and E745 chemical shifts, the general trend is of a more signiﬁ-
cant effect upon linker residues 727–731 than for the residues of the
α1 and α2 helices. This further supports our earlier conclusion that the
linker segment is removed from the micelle core and is located closer
to the phospholipid headgroup.
We also employed a complementary approach for determining
the location of E2-TM in the mixed micelle in order to avoid potential
ambiguities arising from the distribution of the paramagnetic center
within the micelle. Cross-correlated relaxation between phospholipid
(or detergent) and peptide protons has been utilized in various ways
to qualitatively estimate the position of the latter within the micelle
[73–75]. Here we compared the effects of irradiation on protons of
the palmitoyl chain upon the tr-HSQC of E2-TM. Generally, buildup
of cross-relaxation was relatively slow, most likely due to shorter
tumbling time of the mixed LPPG/E2-TM micelles when compared to
other studied systems [73,75] and the ﬂuidity of the LPPG micelle.
Since intramolecular cross-relaxation between E2-TM protons is faster,
this experiment identiﬁes peptide segments in proximitywith irradiated
micelle protons rather than speciﬁc residues. As shown in Fig. 7, irradia-
tion of the overlapping methylene protons (on carbons 4–15) provided
the strongest effect on the E2-TM spectrum.Whereas a peptide oriented
Fig. 7. Cross-relaxation between E2-TM and phospholipid protons. Cross-relaxation
between various LPPG protons and the amide protons of E2-TM is estimated bymeasuring
the ratio between tr-HSQC peaks with and without saturating irradiation on the LPPG
protons. Experimental conditions are detailed in the text. Shown are the results for
irradiation of the terminal methyl protons (top), the overlapping methylene groups on
carbons 4–15 (middle) and the methylene protons on carbon 3 (bottom). Typical errors
in IIRR/I0 values were 0.02–0.04. DPK and RRRRRR designate E2-TM residues which are
not native to E2.
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magnetization transfer towards its center, E2-TM exhibits a clear trend
of decreased transfer ofmagnetization in the linker region in comparison
to the helical segments, and no apparent effect of irradiation of methyl
protons upon linker signals. This conﬁrms our previous conclusion that
the linker region lies closer to the more polar headgroup region.
4. Discussion
Since heterodimerization of the E1/E2 glycoproteins is a mandatory
step for fusion of viral and host cell membranes during infection byHCV
[12,27], and interactions within their TM-domains contribute to this
cellular event, inhibition of this interaction is a promising avenue
for combating HCV infection. Currently there is very little structural
information for E2-TM in a biologically relevant environment or for its
complex with the E1-TM domain. These two considerations form the
primarymotivation for this study. A signiﬁcant hurdle faced by structur-
al investigations of membrane-embedded peptides is the need to syn-
thesize them in sufﬁcient amounts by chemical or recombinant
methods, generally a challenging task due to their strong aggregation
tendency during expression or puriﬁcation [76]. We achieved this
aim by fusing the E2-TM peptide via a linker containing a proteolysis
cleavage site to the MBP C-terminus, adding a solubility-enhancing
Arg6 tag at the peptide C-terminus, and replacing the cysteine residues
with serines to avoid covalent aggregation via disulﬁde bond formation.
Together these factors allowed us to prepare E2-TM samples amenable
to NMR study by solubilization in LPPGmicelles, known to stabilizeMPs
sufﬁciently to allow acquisition of necessary NMR data [33]. Bicelles,
assemblies formed by amixture of short- and long-chain phospholipids
have been proposed as an environment that ideally mimics the native
bilayer and they are less prone to curvature effects [34,77].We note,
however, that the estimated diameter of an LPPG micelle is in excess
of ~50 Ǻ, which should be sufﬁcient to avoid hydrophobic mismatch
effects in the E2-TM helices.
Well-established NMR methods were used to characterize the
conformation adopted by E2-TM within the stabilizing micelles and
the architecture of the E2-TM/LPPG macroassembly in terms of
micellar size and positioning of the peptide. Findings of several
experimental methods concur that E2-TM residues assume an
α-helical conformation. Trp residue W716 demarcates the beginning
of the membrane-embedded domain, located characteristically at the
water-micelle interface. The ﬁrst helical domain, α1, includes residues717–726, and the second domain, α2, spans residues 732–746. Estab-
lishing the helical nature of these regions were (i) secondary chemical
shifts, with agreement between 13C`, 13Cα, and 13Cβ deviations from
random coil values, (ii) protection for solvent exchange observed for
residues 720–726 and 738–743, suggesting that they are the middle
residues in helices, (iii) CD results that are consistent with the presence
of helical domains in E2-TM. The structured nature of these segments
was echoed in the analysis of relaxation measurements, as they exhib-
ited high squared generalized order parameters and low contributions
of local motions. The two helices are connected by a linker segment
spanning residues 727–731, including charged residues D728 and
R730, and here secondary chemical shifts were similar to random coil
values and inconsistent with a helical conformation. However, relaxa-
tion rates R1 and R2 for this region are not signiﬁcantly different from
those measured for the helical segments, and hetNOE values decrease
to ~0.6 but not lower. Overall the linker appears to be only marginally
ﬂexible, and signiﬁcantly more rigid than E2-TM outside the micelle;
indeed, themajor contribution to relaxation in these residues (as deter-
mined by model-free analysis) is the global tumbling of the entire
mixed micelle.
Having identiﬁed the helix–linker–helix architecture of E2-TM,
we continued our study bydetermining the positioning of E2-TMwithin
the micelle using paramagnetic NMR and cross-relaxation measure-
ments. Spin-labels, molecules carrying an unpaired electron which
enhances relaxation in a distance-dependent manner, have been previ-
ously employed for high-resolution NMR study of membrane peptides
and proteins [48]. In the case of the LPPG/E2-TM mixed micelle the
often-used stearate-based nitroxide spin labels [78]were inappropriate,
as they resulted in a destabilizing of the micelle, and the small hydro-
phobic 4-HTB was used instead. Contrary to our initial assumption,
4-HTB exhibited a relatively broad radial distribution in the micelle.
Since large effects were observed for several of the terminal E2-TM
residues, we concluded that effects exhibited by the linker region
(as opposed to the relatively unaffected helical segments) were an
indication of the linker's proximity to the micelle perimeter. Titration
of the paramagnetic Mn2+ ion into the E2-TM sample revealed a
pseudocontact shift effect which can only be explained by a binding of
the ions to the mixed micelle, most likely to the negatively charged
phosphate group. Here, too, the effect was more pronounced for linker
residues when compared to the helical segments, conﬁrming the
earlier conclusion that the linker lies within the micelle closer to the
headgroups rather than at the core of the micelle. Finally, cross-
relaxation between the spectrally overlapping methylene protons
which span the hydrophobic core of the micelle and E2-TM was stron-
gest for the helical regions but weaker for linker residues, once more
establishing their location in the vicinity of the headgroups. Thus, all
three measurements were consistent with the conclusion that E2-TM
does not traverse the LPPGmicelle along its diameter, but rather orients
itself in a manner that brings the linker segment in proximity with the
micelle headgroup.
Based on the combination of NMR results it is possible to suggest a
plausible model for the architecture of the LPPG/E2-TM mixed micelle.
We have shown that (i) E2-TM adopts a helix–linker–helix structure,
deﬁned by residues 717–726, 727–731, and 732–746, respectively, (ii)
the micelle-spanning residues start at W716 and end at the second
arginine residues of the C-terminal tail, (iii) the linker residues are
unstructured, show a degree of ﬂexibility while remaining ordered
relative to the micelle, and (iv) the helix–linker–helix structure is bent,
shifting the linker closer to the charged phosphoglycerol headgroups.
Fig. 8 schematically summarizes these ﬁndings and portrays the ensuing
model of the mixed micelle. One possible explanation for the marginal
ﬂexibility of the linker may be its length (only 5 residues) and its
location between two structured domains. However, another important
contribution may be the concomitant requirements of positioning the
helical domains in the micelle hydrophobic core while allowing linker
residues, speciﬁcally their charged sidechains, to extend into the more
Fig. 8. Summary of NMR-derived global fold and motions of LPPG-embedded E2-TM.
The E2-TM peptide (red) is schematically depicted with representative amino acid
numbering within an LPPG micelle with hydrophobic core (dark gray) and headgroup
region (gradient light gray) shown. An LPPG molecule demonstrates the location of
phospholipid nuclei along the micelle radius. Helices and unstructured segments appear
in cylinders and lines, respectively, with their thickness proportional to their rigidity.
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given orientation relative to the micelle, accounting for the model-free
interpretation of linker relaxation rates.
The presence of charged residues within the membrane-spanning
domain is unusual in MPs, and in most cases indicates a functional role
for these residues; in the case of the E1/E2 interaction, residues K370
(of E1) andD728 (of E2) are known to contribute to heterodimerization
[26,27]. In drawing conclusions from our results the limitations of this
study in LPPG micelles must be recognized. The micelle does not fully
reﬂect the native cell membrane lipid bilayer, and its ﬂuidity may result
in deviation from spherical symmetry upon peptide solubilization.
However, the size of the LPPG micelle should properly accommodate
the E2-TM peptide, suggesting that the helix–linker–helix architecture
is a reasonable representation of the E2 glycoprotein TM domain and
not an artifact of sample preparation. From our results it is clear that
the charged residues exert a signiﬁcant effect on the structure of the
peptide within the micelle, and, presumably, this would be the case in
the biological membrane as well. It is plausible to hypothesize that the
distorted conformation observed in this study is related to the fold
adopted by the HCV E2-TM in the absence of the binding partner
E1, or in the case of an E1 mutation abolishing its stabilizing effect
(e.g. absence of theK370 residue). Thiswould account for the detrimental
effect of such a mutation upon the ability of the E1/E2 heterodimer to
efﬁciently mediate cell fusion. Further studies of the E2-TM peptide,
particularly in complexwith E1-derived peptides, should be instrumental
in shedding additional light on the formation of this key heterodimeric
assembly.
5. Conclusions
In this work we have structurally investigated the TM domain of
the E2 glycoprotein in a membrane-mimicking environment by a com-
bination of improvements in its expression and NMR methodologies.
E2-TM was found to adopt a helix–linker–helix fold, and the charged
residues of the linker segmentwere shown to direct this region to closer
proximity with themicelle headgroups. This may reﬂect the state of theE2 transmembrane domain in the absence of the E1 binding partner or
in cases of a mutation at key E1 residues. Currently underway is a more
detailed study of the structural description of the E1/E2 interaction in
the membrane domain which will greatly enhance our understanding
of which structural elements in the heterodimeric complex are critical
for its formation.Funding
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